Overview
Roche Holding is a Basel-based research health-care company organised into a Pharmaceuticals division and a Diagnostics division.[2] Forbes lists sales of US$74.1bn, the largest of any company outside the United States in this ranking, and profit of US$15.5bn.[2] The Pharmaceuticals division includes Roche’s own business and Chugai, its Japanese subsidiary, while Diagnostics spans centralised and point-of-care testing, molecular diagnostics, tissue diagnostics and diabetes care.[2] The combination means a part of Roche’s revenue comes from instruments and tests rather than medicines, which distinguishes it from most of the drug makers below it. Forbes gives the company’s founding as 1896, by Fritz Hoffmann-La Roche, and its workforce as 112,774 employees.[2] Roche reports in Swiss francs, so the dollar sales figure in this list moves with the exchange rate as well as with underlying demand.
Roche Group strengths and limitations
Strengths
- Largest non-US company by sales
- Diagnostics business adds a second revenue base
- Profit of US$15.5bn
Limitations
- Dollar figures depend on the Swiss franc
- Diagnostics revenue is not pharmaceutical
- Chugai is a listed subsidiary, so part of the profit belongs to minority holders
Appears in
Roche Group peers and competitors
Companies ranked in the same lists as Roche Group.
Novartis- Glencore plc
- Amgen
Pfizer- AbbVie
AstraZeneca PLC
Bayer AG
Novo Nordisk
Sanofi- Bristol Myers Squibb
GSK plc
Gilead Sciences
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.